A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 539 shares of REGN stock, worth $385,099. This represents 1.11% of its overall portfolio holdings.

Number of Shares
539
Previous 329 63.83%
Holding current value
$385,099
Previous $345,000 64.06%
% of portfolio
1.11%
Previous 0.59%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$1024.09 - $1201.76 $215,058 - $252,369
210 Added 63.83%
539 $566,000
Q2 2024

Aug 02, 2024

SELL
$883.2 - $1071.19 $3,532 - $4,284
-4 Reduced 1.2%
329 $345,000
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $436,901 - $480,781
-484 Reduced 59.24%
333 $320,000
Q4 2023

Jan 19, 2024

SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 0.24%
817 $717,000
Q3 2023

Nov 01, 2023

SELL
$692.45 - $844.37 $5,539 - $6,754
-8 Reduced 0.97%
819 $674,000
Q2 2023

Aug 04, 2023

SELL
$700.03 - $830.35 $5.55 Million - $6.59 Million
-7,932 Reduced 90.56%
827 $594,000
Q1 2023

May 05, 2023

BUY
$680.49 - $826.97 $5.51 Million - $6.69 Million
8,093 Added 1215.17%
8,759 $7.2 Million
Q4 2022

Jan 25, 2023

SELL
$705.89 - $766.39 $1,411 - $1,532
-2 Reduced 0.3%
666 $481,000
Q3 2022

Nov 04, 2022

BUY
$573.97 - $724.32 $87,243 - $110,096
152 Added 29.46%
668 $460,000
Q2 2022

Aug 01, 2022

SELL
$548.35 - $738.84 $2,193 - $2,955
-4 Reduced 0.77%
516 $305,000
Q1 2022

May 05, 2022

SELL
$595.12 - $698.43 $26,780 - $31,429
-45 Reduced 7.96%
520 $363,000
Q4 2021

Feb 03, 2022

SELL
$543.48 - $670.97 $543 - $670
-1 Reduced 0.18%
565 $357,000
Q3 2021

Nov 04, 2021

SELL
$574.03 - $680.96 $28,127 - $33,367
-49 Reduced 7.97%
566 $343,000
Q2 2021

Aug 09, 2021

BUY
$472.8 - $558.54 $945 - $1,117
2 Added 0.33%
615 $344,000
Q1 2021

May 11, 2021

SELL
$446.73 - $548.2 $124,637 - $152,947
-279 Reduced 31.28%
613 $290,000
Q4 2020

Jan 27, 2021

SELL
$478.3 - $607.98 $1,434 - $1,823
-3 Reduced 0.34%
892 $431,000
Q3 2020

Nov 12, 2020

SELL
$544.75 - $658.21 $29,961 - $36,201
-55 Reduced 5.79%
895 $501,000
Q1 2020

May 07, 2020

SELL
$336.18 - $494.43 $25,213 - $37,082
-75 Reduced 7.32%
950 $463,000
Q4 2019

Jan 24, 2020

BUY
$274.13 - $376.51 $3,289 - $4,518
12 Added 1.18%
1,025 $385,000
Q3 2019

Oct 29, 2019

BUY
$273.46 - $318.39 $5,469 - $6,367
20 Added 2.01%
1,013 $281,000
Q2 2019

Jul 19, 2019

BUY
$299.6 - $414.82 $115,945 - $160,535
387 Added 63.86%
993 $311,000
Q1 2019

Apr 24, 2019

BUY
$372.08 - $439.57 $21,580 - $25,495
58 Added 10.58%
606 $249,000
Q4 2018

Jan 23, 2019

BUY
$335.82 - $403.04 $184,029 - $220,865
548 New
548 $205,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.